Inventor

YANNI JOHN M

US56 patents

⚠️ This page may combine multiple inventors who share the name “YANNI JOHN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YANNI JOHN M

ALCON LAB INC

Topical use of kappa opioid agonists to treat otic pain

Viscoelastic compositions and methods of use

Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation

Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders

Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides

Ophthalmic viscoelastic compositions

Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications

Substantially pure apraclonidine

Methods using antiallergics and antihistamines

Ophthalmic compositions comprising emedastine and methods for their use

Materials for use in glaucoma filtration devices

Method of preparing human conjunctival mast cells for mast cell stabilization assays

Ophthalmic compositions comprising emedastine and methods for their use

Method of inhibiting cytokine release from human ocular cells

Compositions containing histamine H2 agonists and methods of use in treating allergy and inflammation

ALCON INC

Use of selective PDE IV inhibitors to treat dry eye disorders

Methods for treating otic and ophthalmic infections

Ophthalmic antibiotic compositions containing moxifloxacin

Use of an H1 antagonist and a safe steroid to treat eye conditions

Lipoxin A4 and its analogs for the treatment of dry eye

Method of treating ophthalmic infections with moxifloxacin compositions

Method of treating neurodegenerative disorders of the retina and optic nerve head

Use of NF-κB inhibitors to treat dry eye disorders

Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac

Compositions containing moxifloxacin for treating otic infections

ALCON MFG LTD

Methods of treating ophthalmic, otic and nasal infections and attendant inflammation

Compositions and methods for treating otic, ophthalmic and nasal infections

Topical ophthalmic mast cell stabilizers for treating allergic eye disease

Compositions and methods for treating ophthalmic and otic infections

ROBINS CO INC A H

Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment

Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment

Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions

1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents

ALCON UNIVERSAL LTD

Ophthalmic anti-allergy compositions suitable for use with contact lenses

Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders

Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders

15-Hydroxyeicosatetraenoic acid-related compounds and methods of use

YANNI JOHN M

RNAi-mediated inhibition of histamine receptor H1-related conditions

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders

RNAi-mediated inhibition of histamine receptor H1-related conditions

ALCON RES LTD

RNAi-mediated inhibition of histamine receptor H1-related conditions

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

RNAI-mediated inhibition of tumor necrosis factor α-related conditions

ARROWHEAD RES CORP

RNAi-mediated inhibition of histamine receptor H1-related conditions

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders

RNAi-mediated inhibition of histamine receptor H1-related conditions

(unassigned)

Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders

GOVEK STEVEN P

Heteroarylalkoxy-substituted quinolone inhibitors of PDE4

PRUVYC PHARMA LLC

Method for treating pruritus

ARROWHEAD PHARMACEUTICALS INC

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders